Stocks and Investing
Stocks and Investing
Tue, October 18, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Silvan Tuerkcan Initiated (BNTC) at Buy and Held Target at $68 on, Oct 18th, 2022
Silvan Tuerkcan of JMP Securities, Initiated "Benitec Biopharma Inc." (BNTC) at Buy and Held Target at $68 on, Oct 18th, 2022.
Silvan has made no other calls on BNTC in the last 4 months.
There is 1 other peer that has a rating on BNTC. Out of the 1 peers that are also analyzing BNTC, 0 agree with Silvan's Rating of Hold.
This is the rating of the analyst that currently disagrees with Silvan
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $68 on, Friday, September 23rd, 2022
Contributing Sources